Picture of High Tech Pharm Co logo

106190 High Tech Pharm Co Share Price

0.000.00%
kr flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Momentum

Relative Strength (%)
1m+6.19%
3m+7.71%
6m-11.45%
1yr+15.36%
Volume Change (%)
10d/3m+46.23%
Price vs... (%)
52w High-9.18%
50d MA+11.57%
200d MA+10.26%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital8.99%
Return on Equity7.81%
Operating Margin13.14%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total RevenueKR₩m63,067.7374,462.2773,287.28102,947.2176,772.14n/an/a2.95%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%n/an/an/an/a+38.76n/an/an/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of High Tech Pharm Co EPS forecast chart

Profile Summary

HIGH TECH PHARM. CO., LTD. is a Korea-based company mainly engaged in the manufacture of antibiotic pharmaceutical ingredients for injections. The Company's products include sterile imipenem, sterile cilastatin sodium, sterile blended imipenem and cilastatin sodium, injectable sterile meropenem, injectable sterile panipenem, faropenem and others. The Company distributes its products within domestic market and to overseas markets.

Directors

Last Annual
December 31st, 2023
Last Interim
December 31st, 2023
Incorporated
September 1st, 1998
Public Since
July 28th, 2010
No. of Shareholders
3,345
No. of Employees
121
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
kr flag iconKorea Exchange - KOSDAQ
Shares in Issue
10,633,173

106190 Share Price Performance

Upcoming Events for 106190

Similar to 106190

Picture of AbClon logo

AbClon

kr flag iconKorea Exchange - KOSDAQ

Picture of ADBiotech Co logo

ADBiotech Co

kr flag iconKorea Exchange - KOSDAQ

Picture of Ahn-Gook Pharmaceutical Co logo

Ahn-Gook Pharmaceutical Co

kr flag iconKorea Exchange - KOSDAQ

Picture of Alteogen logo

Alteogen

kr flag iconKorea Exchange - KOSDAQ

Picture of Aminologics Co logo

Aminologics Co

kr flag iconKorea Exchange - KOSDAQ

FAQ